These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 6151218)

  • 1. [Review of histamine H2 receptor antagonists].
    García Plaza A; Pascasio Acevedo JM
    Rev Esp Enferm Apar Dig; 1984 Oct; 66(4):288-94. PubMed ID: 6151218
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antagonists of the histamine H2 receptors in the stomach].
    Landa L
    Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460
    [No Abstract]   [Full Text] [Related]  

  • 3. Histamine H2-receptor antagonists and gastric acid secretion.
    Pounder RE
    Pharmacol Ther; 1984; 26(2):221-34. PubMed ID: 6152495
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The interaction potential of H2 receptor antagonists. A short current review].
    Klotz U; Kroemer HK
    Fortschr Med; 1991 Sep; 109(28):574-6. PubMed ID: 1684557
    [No Abstract]   [Full Text] [Related]  

  • 6. H2-receptor antagonists.
    Nurs Times; 2004 Nov 2-8; 100(44):33. PubMed ID: 15552489
    [No Abstract]   [Full Text] [Related]  

  • 7. Extremely early onset of ranitidine action on human histamine H2 receptors expressed in HEK293 cells.
    Fukushima Y; Ishikawa T; Saitoh T; Tateishi K; Ogihara T; Fujishiro M; Shojima N; Honda M; Kushiyama A; Anai M; Sakoda H; Ono H; Onishi Y; Otsuka H; Katagiri H; Nagai R; Omata M; Asano T
    Digestion; 2003; 68(2-3):145-52. PubMed ID: 14671421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine or ranitidine in renal transplant patients receiving cyclosporine.
    Barri YM; Ramos EL; Balagtas RS; Peterson JC; Karlix JL
    Clin Transplant; 1996 Feb; 10(1 Pt 1):34-8. PubMed ID: 8652895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rat model based on the histamine H2-receptor-activation-induced gastric pathology.
    Del Soldato P
    Pharmacol Res Commun; 1982 Feb; 14(2):175-85. PubMed ID: 6122222
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on peptic ulcer drugs.
    Aronson B
    Am J Nurs; 1998 Jan; 98(1):41-6. PubMed ID: 9455332
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-lasting binding of IT-066 to human histamine H2 receptor.
    Otsuka H; Fukushima Y; Tamai M; Takahashi H; Mori H; Asano T; Katsube T; Ogawa K; Kajiwara T; Ohkawa SI; Saitoh T
    Dig Dis Sci; 2000 Apr; 45(4):796-801. PubMed ID: 10759252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intraventricular histamine and H2 receptor antagonists on intraocular pressure.
    Trzeciakowski JP; Frye GD
    J Ocul Pharmacol; 1987; 3(1):55-61. PubMed ID: 2903203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. 1.
    Feldman M; Burton ME
    N Engl J Med; 1990 Dec; 323(24):1672-80. PubMed ID: 1978250
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic approach in patients with concomitant disease/drug--drug interactions (roxatidine acetate).
    Collins JD
    Scand J Gastroenterol Suppl; 1988; 146():89-99. PubMed ID: 2906472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastric acid secretion and histamine H2 receptor antagonists].
    Gespach C; Emami S; Di Gioia Y; Chastre E
    Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
    [No Abstract]   [Full Text] [Related]  

  • 16. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
    Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is the role of H2 receptor blockers today in ulcer therapy?].
    Creutzfeldt W
    Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
    [No Abstract]   [Full Text] [Related]  

  • 18. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP; Grebenev AL; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract]   [Full Text] [Related]  

  • 19. [New class of pharmacological preparations: histamine H2-receptors blockaders (a review of the literature)].
    Ionov ID
    Farmakol Toksikol; 1978; 41(5):624-32. PubMed ID: 81139
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.